查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1924759

皮下隧道针市场按产品类型、应用、最终用户和分销管道划分－全球预测（2026-2032 年）

Subcutaneous Tunnel Needle Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年皮下隧道针市值为 1.0215 亿美元，预计到 2026 年将成长至 1.1084 亿美元，年复合成长率为 7.11%，到 2032 年将达到 1.6528 亿美元。

主要市场统计数据
基准年 2025 1.0215亿美元
预计年份：2026年 1.1084亿美元
预测年份：2032年 1.6528亿美元
复合年增长率 (%) 7.11%

在各种医疗保健环境中，全面策略性地推广隧道式针头，重点在于其临床效用、手术创新、提高病患安全性和市场相关性。

隧道式穿刺针在多种需要安全、可靠且微创地进入皮下组织的临床操作中发挥着至关重要的作用。这些器械贯穿整个治疗流程，包括诊断程序（如粗针穿刺活检和细针穿刺切片检查）、止痛药和激素给药、疫苗接种、化疗和水化治疗，以及从持续皮下胰岛素输注到每日多次注射等各种胰岛素给药策略。隧道式穿刺针的设计－平衡管腔形态、涂布材料和安全特性－整体影响临床医师操作的便利性、病人的舒适度和后续的治疗效果。

分析重塑隧道式针头发展格局的变革性变化，包括监管重点、技术融合、居家医疗的兴起以及供应链重组。

隧道式针头的市场格局正受到技术、监管和医疗服务趋势共同作用的重塑，这些趋势正推动产品演进和策略重新定位。器械设计人员优先考虑能够减少针刺伤和交叉感染的安全设计方案，加速从传统结构到整合式主动和被动安全机制的过渡。同时，材料科学的进步，例如改进的聚合物涂层和生物相容性表面处理，正在改善滑动特性，减少组织损伤，并延长重复使用环境下的功能寿命。这些产品层面的创新与临床医生对能够在各种应用中保持性能稳定的器材的偏好密切相关。

评估2025年美国关税变化对医疗设备製造、筹资策略、价格压力和全球供应商多元化的累积影响

美国2025年关税政策的变化造成了复杂的商业环境，对医疗设备相关人员的采购、製造和采购策略产生了重大影响。进口零件和成品的关税调整增加了全球采购的成本考量，促使许多企业重新评估其供应商组合，并考虑将生产转移到近岸或国内，以保护生产免受贸易波动的影响。这种供应商策略的调整直接影响前置作业时间、新製造合作伙伴的资格认证以及扩大本地产能所需的资本规划。

透过整合应用、最终用户、分销管道和产品类型进行详细的細項分析，以製定跨临床管道的目标策略和产品定位。

細項分析重点阐述了优化不同临床和商业通路产品开发和商业化策略的关键解决方案。按应用领域划分，市场可分为切片检查程序（粗针穿刺活检和细针穿刺切片检查需要不同的管腔尺寸和针尖配置）、药物输送方式（镇痛、荷尔蒙疗法、疫苗接种等，其中无菌性、剂量准确性和输送系统兼容性至关重要）、输液治疗应用（例如化疗、水化荷尔蒙疗法和疼痛管理，其中耐用性与输液设备集成和输液设备，其中耐用性管理设备和治疗设备的持续性管理，其中耐用性管理，其中耐用性反应设备（重要和治疗设备）。这种应用层面的细分揭示了设计上的权衡取舍和临床训练需求。

区域趋势分析突显了美洲、欧洲、中东、非洲和亚太地区在采用模式、监管环境、报销趋势和成长驱动因素方面的差异。

区域趋势对医疗器材的普及、监管合规和商业性策略有着深远的影响。认识到这些差异对于制定市场准入和扩大策略至关重要。在美洲，采购趋势可能受到集团采购动态、不断变化的报销规则以及朝向以以金额为准的采购模式稳步转变的影响，这种模式奖励那些能够显着提高安全性和效率的产品。该地区的临床偏好模式通常与那些能够降低併发症发生率和缩短手术时间的创新技术的快速普及相吻合。

竞争情报概述，重点在于塑造隧道针竞争格局的製造商类型、创新重点、伙伴关係模式和通路策略。

隧道式针头领域的竞争格局呈现出几种截然不同的模式和策略行动。成熟的医疗设备製造商通常利用规模经济、丰富的产品系列和深厚的监管专业知识来维持市场进入和供应稳定性。这些老牌企业往往会投资于产品迭代改进和安全功能，以保护现有基本客群并满足竞标要求。同时，专注于安全器材的专业公司和敏捷的Start-Ups则强调差异化设计、新型材料和以用户为中心的人体工学，以取代现有产品或开闢新的临床应用领域。契约製造和专业零件公司发挥关键作用，它们能够实现快速原型製作、经济高效的大规模生产和柔软性的生产模式，从而有可能缩短创新型公司的产品上市时间。

为隧道针段的产业领导者提供切实可行的策略建议，以优化产品设计、市场进入、供应链韧性、商业化和政策协调。

产业领导者应采取一系列协调一致的策略行动，将产品开发、供应链韧性和商业性执行结合，以获取并维持价值。优先考虑能够降低临床风险并简化门诊和居家医疗环境使用的安全设计，并将产品上市与强有力的医疗专业人员教育计划和循证实践相结合，以加速产品推广倡议。同时，应实现供应商多元化，并探索近岸外包方案，以降低贸易中断和关税波动带来的风险，并实施严格的供应商筛选流程，以确保产品品质和合规性。

透明的调查方法，详细说明了资料来源、相关人员访谈、检验过程以及为确保研究结果的可靠性和可重复性而采用的分析框架。

本研究综合分析采用混合方法，强调对一手和二手资讯进行三角验证，以确保得出可靠的结论。一手研究包括对临床、采购、分销和製造环节的关键相关人员相关者进行深度访谈，以捕捉医疗设备性能、购买行为和未满足需求等方面的经验细节。这些定性见解辅以对监管文件、器械标准和技术规范的分析，以检验性能声明并识别合规趋势。二级资讯来源包括同行评审的临床文献、行业白皮书和已发布的监管指导文件，以阐明临床和政策驱动因素的背景。

这份简明扼要的报告总结了关键研究结果，重点阐述了隧道式针技术相关相关人员的策略要务、营运风险和投资重点。

累积分析凸显了隧道式针技术相关人员的明确策略要务。产品层面的创新，特别是安全特性和材料改进，仍然是降低临床风险并在从三级医疗中心到居家医疗等各种环境中创造差异化价值的主要手段。同时，关税调整、区域监管差异以及向门诊和主导患者为中心的护理模式转变等宏观因素，正迫使各机构采取更灵活的供应链策略，并根据地区和通路调整其商业性策略。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的皮下隧道针市场

  • 传统隧道针
    • 塑胶涂层针头
    • 钢针
  • 安全隧道针

9. 按应用分類的皮下隧道针市场

  • 切片检查
    • 核心针穿刺切片
    • 细针穿刺法
  • 药物输送
    • 服用止痛药
    • 荷尔蒙疗法
    • 疫苗接种
  • 点滴疗法
    • 化疗
    • 水疗法
    • 疼痛管理
  • 胰岛素给药
    • 持续皮下胰岛素输注
    • 每日多次注射

第十章 依最终用户分類的皮下隧道针市场

  • 门诊治疗中心
    • 门诊部
    • 专科诊所
  • 居家医疗环境
  • 医院

第十一章 皮下隧道针市场（依通路划分）

  • 离线
  • 在线的
    • 公司网站
    • 电子商务平台

第十二章 皮下隧道针市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 皮下隧道针市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国皮下隧道针市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国隧道式皮下注射针市场

第十七章：中国皮下隧道针市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Fresenius Medical Care AG & Co. KGaA
  • Hangzhou Golden Stone Medical Technology Co., Ltd.
  • HMD Healthcare Ltd.
  • ICU Medical, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Nipro Medical Corporation
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Smiths Medical
  • Teleflex Incorporated
  • Terumo Corporation
  • Vygon SA
Product Code: MRR-7A380DA7C482

The Subcutaneous Tunnel Needle Market was valued at USD 102.15 million in 2025 and is projected to grow to USD 110.84 million in 2026, with a CAGR of 7.11%, reaching USD 165.28 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 102.15 million
Estimated Year [2026] USD 110.84 million
Forecast Year [2032] USD 165.28 million
CAGR (%) 7.11%

Comprehensive strategic introduction to subcutaneous tunnel needles emphasizing clinical utility, procedural innovation, patient safety improvements, and market relevance across care settings

Subcutaneous tunnel needles play a pivotal role in a wide array of clinical procedures where secure, reliable, and minimally invasive access to subcutaneous tissue is required. These devices are utilized across diagnostic interventions such as core needle biopsy and fine needle aspiration, as well as therapeutic workflows that include analgesic and hormonal drug delivery, vaccination, infusion therapy for chemotherapy or hydration, and insulin administration strategies ranging from continuous subcutaneous insulin infusion to multiple daily injections. The design of tunnel needles-balancing lumen geometry, coating materials, and safety features-directly influences clinician handling, patient comfort, and downstream therapy efficacy.

Over recent years, the needle category has evolved beyond a purely mechanical instrument to become a critical node in broader clinical pathways. Safety-engineered designs and compatibility with infusion sets and insulin delivery systems have increased the importance of cross-functional alignment among device designers, clinicians, and procurement specialists. Moreover, shifts in care delivery toward ambulatory and homecare settings have amplified the need for devices that are intuitive for non-specialist users while meeting rigorous sterility and performance standards. This introduction frames the device's clinical significance and situates it within the operational and regulatory priorities that shape adoption decisions in modern healthcare systems.

Analysis of transformative shifts reshaping subcutaneous tunnel needle development including regulatory emphasis, technological convergence, homecare adoption, and supply chain realignment

The landscape for subcutaneous tunnel needles is being reshaped by a confluence of technological, regulatory, and care-delivery trends that are driving product evolution and strategic repositioning. Device designers are prioritizing safety-engineered solutions to reduce needlestick injuries and cross-contamination, and this emphasis is accelerating the migration from conventional constructions toward integrated active and passive safety mechanisms. Concurrently, material science advances-such as improved polymer coatings and biocompatible finishes-are enhancing glide characteristics, reducing tissue trauma, and lengthening functional life in repeated-use contexts. These product-level innovations are tightly coupled with clinician preference trajectories that favor devices delivering consistent performance across diverse applications.

At the systems level, care delivery models are pivoting toward outpatient and home-based care, which is increasing demand for user-centric devices that can be employed by non-specialists and patients themselves with minimal training. Digital convergence is also notable: connectivity and smart-device compatibility are emerging as differentiators where needles interface with pumps or monitoring platforms. Regulatory bodies are sharpening focus on post-market surveillance and device traceability, prompting manufacturers to strengthen quality systems and supply chain transparency. Taken together, these shifts are not incremental; they are reframing how manufacturers, healthcare providers, and distributors approach design, reimbursement, and market access for subcutaneous tunnel needle technologies.

Assessment of cumulative effects of United States tariff changes in 2025 on manufacturing, procurement strategies, pricing pressure, and global supplier diversification for medical devices

Changes in United States tariff policy in 2025 have created a complex operating environment that materially affects sourcing, manufacturing, and procurement strategies for medical device stakeholders. Tariff adjustments on imported components and finished devices have increased the cost considerations attached to global procurement, prompting many organizations to reassess supplier portfolios and evaluate nearshoring or onshoring as mechanisms to insulate production from trade volatility. This recalibration of supplier strategy has an immediate bearing on lead times, qualifying new manufacturing partners, and the capital planning required to scale localized production capability.

Procurement teams are responding by diversifying sourcing pools, negotiating longer-term contracts to stabilize input pricing, and incorporating total-cost-of-ownership analyses that account for tariff exposure. For smaller suppliers and niche component manufacturers, tariff-driven cost pressures may reduce competitiveness unless offset by operational efficiency or specialization. At the clinical adoption front, purchasers and health systems are sensitive to device cost trajectories, which can influence formulary decisions and tender outcomes. Regulatory compliance and customs documentation workloads have also increased, placing additional administrative burdens on distributors and importers. Collectively, these effects underscore the necessity for strategic hedging, improved demand forecasting, and more integrated supplier relationships to maintain supply continuity and manage cost impacts in a post-tariff adjustment landscape.

In-depth segmentation insights integrating application, end user, distribution channel, and product type to inform targeted strategy and product positioning across clinical pathways

Segmentation analysis provides critical resolution for tailoring product development and commercialization strategies across distinct clinical and commercial pathways. Based on application, the market spans biopsy procedures-where core needle biopsy and fine needle aspiration each demand different lumen sizes and tip geometries-drug delivery modalities including analgesic delivery, hormone therapy, and vaccination that emphasize sterility, dosing precision, and compatibility with delivery systems, infusion therapy applications such as chemotherapy administration, hydration therapy, and pain management that require durability and integration with infusion sets, and insulin administration where continuous subcutaneous insulin infusion and multiple daily injection approaches necessitate compatibility with pump interfaces and patient-managed devices. This application-level granularity informs design trade-offs and clinical training needs.

Based on end user, the landscape encompasses ambulatory care centers with outpatient and specialty clinics that prioritize throughput and ease of use, homecare settings including both assisted care and self-care environments that demand robust safety features and clear user instructions, and hospitals differentiated by large tertiary centers versus small and medium hospitals that balance procurement sophistication with operational constraints. Understanding the differential procurement cycles and clinical competencies across these end users is essential for channel strategy and service models. Based on distribution channel, stakeholders must navigate hospital pharmacy relationships, online pharmacy platforms operated by company-owned retail websites or third-party e-commerce platforms, and retail pharmacy networks including chain and independent pharmacies, each with distinct fulfillment, regulatory, and customer-engagement dynamics. Based on product type, distinctions between conventional tunnel needles-available as plastic-coated or steel needles-and safety tunnel needles with active or passive safety systems shape both clinical adoption and regulatory pathways. Integrating insights from these segmentation lenses enables targeted value propositions, optimized product portfolios, and differentiated go-to-market approaches aligned with clinical workflows and purchaser priorities.

Regional landscape analysis highlighting varied adoption patterns, regulatory environments, reimbursement dynamics, and growth enablers across the Americas, EMEA, and Asia-Pacific regions

Regional dynamics exert a profound influence on device adoption, regulatory compliance, and commercial approaches, and recognizing these differences is essential for developing market entry and expansion strategies. In the Americas, procurement tends to be influenced by consolidated group purchasing dynamics, evolving reimbursement rules, and a steady shift toward value-based purchasing that rewards demonstrable safety and efficiency gains. Clinical preference patterns in this region often align with rapid uptake of innovations that reduce complication rates and operating time.

In Europe, the Middle East & Africa, heterogeneous regulatory frameworks and varied reimbursement environments create a patchwork of access scenarios. Manufacturers operating here must navigate harmonized standards in some jurisdictions alongside localized regulatory nuance in others, and market entry often requires tailored evidence packages that reflect regional clinical practice variations. Meanwhile, in Asia-Pacific, rapid expansion of ambulatory care infrastructure, rising prevalence of chronic conditions including diabetes, and government-led investments in domestic manufacturing capacity are accelerating demand. However, this region also presents diverse procurement models and pricing sensitivities that demand flexible commercial approaches. Across all regions, local regulatory expectations, clinician training needs, and supply chain resilience considerations will determine the pace and scale of adoption for subcutaneous tunnel needle technologies.

Competitive intelligence overview describing manufacturer archetypes, innovation focal points, partnership models, and channel strategies shaping the tunnel needle competitive environment

Competitive dynamics in the tunnel needle space are characterized by several distinct archetypes and strategic behaviors. Established medical-device manufacturers typically leverage scale, breadth of portfolio, and deep regulatory expertise to maintain market access and supply reliability. These incumbents often invest in iterative product enhancements and safety feature rollouts to protect installed bases and to respond to tender requirements. Conversely, specialized safety-device firms and nimble startups emphasize differentiated design, novel materials, and user-centric ergonomics to displace legacy offerings or to create new clinical niches. Contract manufacturers and component specialists play a pivotal role by enabling rapid prototyping, cost-effective scale-up, and production flexibility, which can accelerate time-to-market for innovation-minded companies.

Distribution partners, including hospital procurement consortia, pharmacy chains, and e-commerce platforms, shape product availability and purchase experience. Strategic partnerships between manufacturers and clinical advocacy groups or professional societies can accelerate clinician adoption by generating practice-oriented evidence and training resources. Intellectual property around safety mechanisms and material science often determines competitive positioning, while manufacturing footprint decisions influence pricing and lead-time advantages. For stakeholders assessing the competitive landscape, the intersection of regulatory proficiency, channel alignment, manufacturing resilience, and design differentiation will determine long-term viability and growth potential in the tunnel needle category.

Actionable strategic recommendations for industry leaders to optimize product design, market access, supply resilience, commercialization, and policy engagement in the tunnel needle sector

Industry leaders should pursue a set of coordinated strategic actions that align product development, supply chain resilience, and commercial execution to capture and sustain value. Prioritize the deployment of safety-engineered designs that demonstrably reduce clinical risk and simplify use in ambulatory and homecare settings, and couple product launches with robust clinician education programs and evidence-generation initiatives to accelerate adoption. Simultaneously, diversify supplier footprints and evaluate nearshoring options to reduce exposure to trade disruptions and tariff volatility, while implementing rigorous supplier qualification processes to maintain quality and regulatory compliance.

Commercially, invest in channel orchestration that recognizes the differing needs of hospital pharmacies, online platforms, and retail outlets, and build pricing and contracting models that reflect total cost of care benefits rather than unit price alone. Forge partnerships with infusion device and insulin delivery ecosystem players to ensure interoperability and to capture integrated value propositions. Operationally, strengthen post-market surveillance mechanisms and device traceability to meet evolving regulatory scrutiny and to support continuous improvement. Finally, align R&D roadmaps with clear go-to-market strategies, prioritizing modularity in design to address multiple applications and end users with a smaller number of validated product families. These actions, taken together, will enhance competitive resilience and position organizations to respond to near-term market disruptions while building long-term differentiation.

Transparent research methodology detailing data sources, stakeholder interviews, validation processes, and analytical frameworks employed to ensure robust insights and reproducibility

The research synthesis is grounded in a mixed-methods approach that emphasizes triangulation of primary and secondary information to ensure robust and defensible insights. Primary research included in-depth interviews with key stakeholders across clinical practice, procurement, distribution, and manufacturing to capture experiential nuances around device performance, purchasing behavior, and unmet needs. These qualitative inputs were complemented by analysis of regulatory filings, device standards, and technical specifications to validate performance claims and to identify compliance trends. Secondary sources encompassed peer-reviewed clinical literature, industry white papers, and publicly available regulatory guidance documents to contextualize clinical and policy drivers.

Data integrity was reinforced through cross-validation of interview findings against documented clinical procedures and procurement patterns, and through scenario-based testing of tariff and supply-chain impacts to assess strategic responses. Analytical frameworks applied include value-chain mapping, segmentation analysis by application, end user, distribution channel, and product type, and regional regulatory comparators. Throughout, documented inclusion and exclusion criteria guided source selection to avoid bias, and findings were subjected to internal peer review to ensure clarity, accuracy, and actionable relevance for decision-makers.

Concise synthesis of critical findings emphasizing strategic imperatives, operational risks, and investment priorities for stakeholders engaged with subcutaneous tunnel needle technologies

The cumulative analysis underscores a clear set of strategic imperatives for stakeholders engaged with subcutaneous tunnel needle technologies. Product-level innovation-particularly around safety features and material improvements-remains a primary lever to reduce clinical risk and to create differentiated value in settings that range from tertiary hospitals to homecare. Simultaneously, macro-level forces including tariff adjustments, regional regulatory heterogeneity, and the shift toward ambulatory and patient-directed care require organizations to adopt more agile supply chain strategies and to tailor commercial approaches by region and channel.

For decision-makers, the path forward involves balancing near-term operational resilience with long-term investment in differentiated product capabilities. Strengthened partnerships with distribution and clinical stakeholders, rigorous post-market surveillance, and targeted segmentation-driven product portfolios will collectively improve adoption outcomes and mitigate exposure to external shocks. In sum, aligning innovation, supply chain, and market-access initiatives will be essential to capture the strategic opportunities presented by evolving care models and regulatory expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Subcutaneous Tunnel Needle Market, by Product Type

  • 8.1. Conventional Tunnel Needle
    • 8.1.1. Plastic Coated Needle
    • 8.1.2. Steel Needle
  • 8.2. Safety Tunnel Needle

9. Subcutaneous Tunnel Needle Market, by Application

  • 9.1. Biopsy
    • 9.1.1. Core Needle Biopsy
    • 9.1.2. Fine Needle Aspiration
  • 9.2. Drug Delivery
    • 9.2.1. Analgesic Delivery
    • 9.2.2. Hormone Therapy
    • 9.2.3. Vaccination
  • 9.3. Infusion Therapy
    • 9.3.1. Chemotherapy Administration
    • 9.3.2. Hydration Therapy
    • 9.3.3. Pain Management
  • 9.4. Insulin Administration
    • 9.4.1. Continuous Subcutaneous Insulin Infusion
    • 9.4.2. Multiple Daily Injection

10. Subcutaneous Tunnel Needle Market, by End User

  • 10.1. Ambulatory Care Centers
    • 10.1.1. Outpatient Clinics
    • 10.1.2. Specialty Clinics
  • 10.2. Homecare Settings
  • 10.3. Hospitals

11. Subcutaneous Tunnel Needle Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online
    • 11.2.1. Company Websites
    • 11.2.2. eCommerce Platforms

12. Subcutaneous Tunnel Needle Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Subcutaneous Tunnel Needle Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Subcutaneous Tunnel Needle Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Subcutaneous Tunnel Needle Market

16. China Subcutaneous Tunnel Needle Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AngioDynamics, Inc.
  • 17.6. Argon Medical Devices, Inc.
  • 17.7. B. Braun SE
  • 17.8. Baxter International Inc.
  • 17.9. Becton, Dickinson and Company
  • 17.10. Boston Scientific Corporation
  • 17.11. Cardinal Health, Inc.
  • 17.12. Cook Medical LLC
  • 17.13. Fresenius Medical Care AG & Co. KGaA
  • 17.14. Hangzhou Golden Stone Medical Technology Co., Ltd.
  • 17.15. HMD Healthcare Ltd.
  • 17.16. ICU Medical, Inc.
  • 17.17. Medtronic plc
  • 17.18. Merit Medical Systems, Inc.
  • 17.19. Nipro Medical Corporation
  • 17.20. Romsons Scientific & Surgical Pvt. Ltd.
  • 17.21. Smiths Medical
  • 17.22. Teleflex Incorporated
  • 17.23. Terumo Corporation
  • 17.24. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PLASTIC COATED NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PLASTIC COATED NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PLASTIC COATED NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY STEEL NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY STEEL NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY STEEL NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY SAFETY TUNNEL NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY SAFETY TUNNEL NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY SAFETY TUNNEL NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CORE NEEDLE BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ANALGESIC DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ANALGESIC DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ANALGESIC DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HORMONE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HORMONE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY VACCINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY VACCINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY VACCINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CHEMOTHERAPY ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CHEMOTHERAPY ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CHEMOTHERAPY ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HYDRATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HYDRATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HYDRATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY MULTIPLE DAILY INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY MULTIPLE DAILY INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY MULTIPLE DAILY INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 211. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 212. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 214. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. GCC SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 243. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 245. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 247. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 248. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. G7 SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 258. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 259. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 260. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 262. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. NATO SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY CONVENTIONAL TUNNEL NEEDLE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY BIOPSY, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY INSULIN ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA SUBCUTANEOUS TUNNEL NEEDLE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)